Sodium fusidate and increased remission rate of insulin-dependent diabetes mellitus
Ferdinando Nicoletti(University of Catania), C Zanussi(University of Catania), L Mughini(University of Milan), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Tony Palermo(University of Milan), M Lunetta(University of Catania), MaurizioDi Mauro(University of Milan), D Papalia(University of Milan), Manuela Caruso‐Nicoletti(University of Catania), R. Carmona Vigo(University of Milan)
Cited by 23
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508